These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 18797356)

  • 41. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
    Wagenmakers MA; Boogaarts HD; Roerink SH; Timmers HJ; Stikkelbroeck NM; Smit JW; van Lindert EJ; Netea-Maier RT; Grotenhuis JA; Hermus AR
    Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
    Dehdashti AR; Gentili F
    Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repeat transsphenoidal surgery for Cushing's disease.
    Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
    J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
    Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
    Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
    Rollin G; Ferreira NP; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrent Cushing's disease after transsphenoidal surgery.
    Tahir AH; Sheeler LR
    Arch Intern Med; 1992 May; 152(5):977-81. PubMed ID: 1580725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
    Brito LP; Lerário AM; Bronstein MD; Soares IC; Mendonca BB; Fragoso MC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E271-9. PubMed ID: 20660043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pitfalls in the management of Cushing's disease.
    Bademci G
    J Clin Neurosci; 2007 May; 14(5):401-8; discussion 409. PubMed ID: 17386367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.
    Thompson SK; Hayman AV; Ludlam WH; Deveney CW; Loriaux DL; Sheppard BC
    Ann Surg; 2007 May; 245(5):790-4. PubMed ID: 17457173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.
    Johnston PC; Kennedy L; Hamrahian AH; Sandouk Z; Bena J; Hatipoglu B; Weil RJ
    Pituitary; 2017 Aug; 20(4):430-440. PubMed ID: 28265841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effects of adrenalectomy on the treatment of Cushing disease].
    Xing B; Zhang N; Ren ZY; Su CB; Wang RZ; Yang Y; Ma WB; Li YN
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):592-4. PubMed ID: 18844054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pituitary function after selective adenomectomy for Cushing's disease.
    Post FA; Soule SG; De Villiers JC; Levitt NS
    Br J Neurosurg; 1995; 9(1):41-6. PubMed ID: 7786425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics.
    Costenaro F; Rodrigues TC; Rollin GA; Ferreira NP; Czepielewski MA
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):411-8. PubMed ID: 23895112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of endoscopic transsphenoidal surgery for Cushing's disease.
    Brady Z; Garrahy A; Carthy C; O'Reilly MW; Thompson CJ; Sherlock M; Agha A; Javadpour M
    BMC Endocr Disord; 2021 Mar; 21(1):36. PubMed ID: 33658018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The therapy of Cushing's disease in adults and children: an update.
    Juszczak A; Ertorer ME; Grossman A
    Horm Metab Res; 2013 Feb; 45(2):109-17. PubMed ID: 23225246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiosurgery for Cushing's disease after failed transsphenoidal surgery.
    Sheehan JM; Vance ML; Sheehan JP; Ellegala DB; Laws ER
    J Neurosurg; 2000 Nov; 93(5):738-42. PubMed ID: 11059652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure.
    Pecori Giraldi F; Toja PM; De Martin M; Maronati A; Scacchi M; Omboni S; Cavagnini F; Parati G
    Horm Metab Res; 2007 Dec; 39(12):908-14. PubMed ID: 18046661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.
    Hassan-Smith ZK; Sherlock M; Reulen RC; Arlt W; Ayuk J; Toogood AA; Cooper MS; Johnson AP; Stewart PM
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1194-201. PubMed ID: 22278423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.